Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Nephrology|March 30, 2010
Mexican-American admixture mapping analyses for diabetic nephropathy in type 2 diabetes mellitusSharon Adler, Madeleine Pahl, Hanna Abboud, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 6, 2008
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trialStuart M Sprague, Hanna Abboud, Ping Qiu, et al.
Acta Diabetologica|March 11, 2015
Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitusFranco Folli, Giuseppe Daniele, Sherry Werner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2007
Genome-wide scans for microalbuminuria in Mexican Americans: the San Antonio Family Heart StudyNedal Arar, Subrata Nath, Farook Thameem, et al.
Neurochemical Research|March 6, 2008
Role of tuberin in neuronal degenerationSamy L Habib, David Michel, Eliezer Masliah, et al.
American Journal of Nephrology|October 5, 2007
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysisEdward A Ross, Jin Tian, Hanna Abboud, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.
Diabetes/Metabolism Research and Reviews|January 31, 2006
A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American familyDonna M Lehman, Jeanette Hamlington, Kelly J Hunt, et al.
American Journal of Nephrology|March 18, 2006
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4Hanna Abboud, Daniel Coyne, Olgierd Smolenski, et al.
Pageof 2